Heart rate in coronary artery disease: should we lower it?

Kelly Axsom1, Sripal Bangalore

  • 1The Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, NY, 10016, USA.

Insights

Elevated resting heart rate is a risk factor for cardiovascular events. This study explores if selectively lowering heart rate with ivabradine benefits patients with stable coronary artery disease, without heart failure.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Elevated resting heart rate (RHR) is an independent risk factor for cardiovascular morbidity and mortality.
  • In coronary artery disease (CAD), high RHR exacerbates myocardial ischemia by reducing diastolic filling time and increasing cardiac workload.
  • The prognostic significance of RHR and the efficacy of pharmacological heart rate reduction remain unclear.

Purpose of the Study:

  • To investigate the potential benefits of selectively lowering heart rate with ivabradine in patients with stable coronary artery disease without heart failure.
  • To differentiate the effects of heart rate reduction from other cardiovascular actions of medications like beta-blockers.

Main Methods:

  • Review of existing literature on heart rate, cardiovascular outcomes, and pharmacological interventions.
  • Analysis of the mechanism of action of ivabradine, focusing on selective I(f) current inhibition.
  • Comparison of ivabradine's effects with those of beta-blockers in cardiovascular patients.

Main Results:

  • Ivabradine selectively lowers heart rate by inhibiting the I(f) current, without other significant cardiovascular effects.
  • Beta-blockers, while lowering heart rate, also possess other cardiovascular effects, complicating the interpretation of their benefits.
  • Early trials suggest promise for ivabradine in heart failure patients.

Conclusions:

  • Ivabradine represents a novel therapeutic approach targeting heart rate reduction selectively.
  • Further research is needed to establish the efficacy and safety of ivabradine in patients with stable coronary artery disease without heart failure.
  • Distinguishing the direct effects of heart rate reduction from other drug-induced effects is crucial for optimizing cardiovascular treatment.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...